Most cited papers from Acura Kliniken

Acura Kliniken

What are the most cited papers from Acura Kliniken?

The most cited paper from Acura Kliniken is "Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study" (William Stohl, Andreas Schwarting, Masato Okada et al., 2017), with 429 citations. Next come "Familial chilblain lupus due to a gain-of-function mutation in STING" (310) and "Satisfaction with information and unmet information needs in men and women with cancer" (236).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 19 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology Open access	24 Jan 2017	429
2	Familial chilblain lupus due to a gain-of-function mutation in STING Nadja König, Christoph Fiehn, Christine Wolf et al. · Annals of the Rheumatic Diseases Open access	27 Aug 2016	310
3	Satisfaction with information and unmet information needs in men and women with cancer Hermann Faller, Uwe Koch, Elmar Brähler et al. · Journal of Cancer Survivorship	8 May 2015	236
4	B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE) Tamara Möckel, Fabio Basta, Julia Weinmann‐Menke et al. · Autoimmunity Reviews	16 Dec 2020	226
5	Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course Lorenzo Cavagna et al. · Journal of Clinical Medicine Open access114 authors	18 Nov 2019	222
6	Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New Fabio Basta, Federica Fasola, Konstantinos Triantafyllias et al. · Rheumatology and Therapy Open access	2 Jun 2020	221
7	Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis Farah Tamirou, David P. D’Cruz, Shirish R Sangle et al. · Annals of the Rheumatic Diseases Open access	10 Mar 2015	215
8	Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) Hans‐Peter Tony et al. · Arthritis Research & Therapy Open access	13 May 2011	212
9	Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study Judith Haschka et al. · Annals of the Rheumatic Diseases	7 Feb 2015	203
10	Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome Lorenzo Cavagna et al. · Medicine Open access	Aug 2015	181
11	Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features Rudolf Mierau et al. · Arthritis Research & Therapy Open access	21 Oct 2011	174
12	Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases Gergely Bodis, Victoria Toth, Andreas Schwarting · Rheumatology and Therapy Open access	7 Mar 2018	167
13	Twelve-Month and Lifetime Prevalence of Mental Disorders in Cancer Patients Susanne Kuhnt, Elmar Brähler, Hermann Faller et al. · Psychotherapy and Psychosomatics Open access	2016	155
14	Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer Hermann Faller, Joachim Weis, Uwe Koch et al. · Journal of Psychosomatic Research	16 Dec 2015	154
15	Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response Jutta Bauhammer, Norbert Blank, Regina Max et al. · The Journal of Rheumatology	Jun 2016	147
16	S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten Christoph Fiehn et al. · Zeitschrift für Rheumatologie Open access	29 Jun 2018	146
17	Extracellular Vesicle Subtypes Released From Activated or Apoptotic T-Lymphocytes Carry a Specific and Stimulus-Dependent Protein Cargo Christine Tucher, Konrad Alexander Bode, Petra Schiller et al. · Frontiers in Immunology Open access	15 Mar 2018	128
18	Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Ekkehard Grünig, Felicitas Maier, Nicola Ehlken et al. · Arthritis Research & Therapy Open access	18 Jun 2012	124
19	Utilization of professional psychological care in a large German sample of cancer patients Hermann Faller, Joachim Weis, Uwe Koch et al. · Psycho-Oncology	22 Jun 2016	108
20	Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature Laurent Arnaud, Pierre Edouard Gavand, Rheinardt Voll et al. · Lara D. Veeken Review	14 Nov 2018	106
21	Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment Jürgen Rech et al. · Annals of the Rheumatic Diseases Open access	20 Oct 2015	95
22	Management of sexual dysfunction due to antipsychotic drug therapy Hannah Maren Schmidt, Mathias Hagen, Levente Kriston et al. · Cochrane Database of Systematic Reviews Open access	8 Nov 2012	91
23	First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study Andreas Schwarting, Johann Oltmann Schroeder, Tobias Alexander et al. · Rheumatology and Therapy Open access	Nov 2016	87
24	Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group on Behalf of AENEAS (American and European NEtwork of Antisynthetase Syndrome) C et al. · Clinical Reviews in Allergy & Immunology	19 Jan 2016	81
25	Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis Christopher P. Denton, Eric HACHULLA, Gabriela Riemekasten et al. · Arthritis & Rheumatology Open access	28 Nov 2017	73
26	S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012 K. Krüger et al. · Zeitschrift für Rheumatologie	28 Aug 2012	71
27	The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort Maria Grazia Lazzaroni et al. · Lara D. Veeken Open access	11 Feb 2021	70
28	Genetics and novel aspects of therapies in systemic lupus erythematosus Manfred Relle, Julia Weinmann‐Menke, Eva Scorletti et al. · Autoimmunity Reviews	9 Jul 2015	70
29	Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension Christian Nagel, Philipp Henn, Nicola Ehlken et al. · Arthritis Research & Therapy Open access	18 Jun 2015	66
30	Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study Elena Bartoloni et al. · Autoimmunity Reviews	29 Jan 2017	64
31	Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs Camille Pinto Figueiredo et al. · Annals of the Rheumatic Diseases	21 Jun 2016	63
32	Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men Andreas Schwarting, Manfred Relle, Myriam Meineck et al. · Lupus	28 Jun 2017	62
33	Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. Miguel Ángel González-Gay et al. · PubMed Open access	24 Apr 2018	57
34	STRESSORS, SYMPTOM PROFILE, AND PREDICTORS OF ADJUSTMENT DISORDER IN CANCER PATIENTS. RESULTS FROM AN EPIDEMIOLOGICAL STUDY WITH THE COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW, ADAPTATION FOR ONCOLOGY (CIDI-O) Bianca Hund, Katrin Reuter, Martin Christian Härter et al. · Depression and Anxiety Open access	16 Oct 2015	53
35	Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes Laura Claßen, Lars‐Oliver Tykocinski, Felix Wiedmann et al. · European Journal of Immunology Open access	30 Jun 2017	45
36	S3-Leitlinie „Screening, Diagnostik und Behandlung des schädlichen und abhängigen Tabakkonsums“ Anil Krishnaram Batra, Kay Uwe Petersen, Eva Hoch et al. · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice	Jun 2016	44
37	Training of Dental Professionals in Motivational Interviewing can Heighten Interdental Cleaning Self-Efficacy in Periodontal Patients Johan Peter Woelber, Narin Spann-Aloge, Gilgamesh Hanna et al. · Frontiers in Psychology Open access	24 Feb 2016	38
38	Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus Laurent Arnaud, Philippe Mertz, Zahir Amoura et al. · Lara D. Veeken	Oct 2020	37
39	Microvesicles released by apoptotic human neutrophils suppress proliferation and IL‐2/IL‐2 receptor expression of resting T helper cells Guifen Shen, Stefan Krienke, Petra Schiller et al. · European Journal of Immunology Open access	11 Mar 2017	34
40	Response to: ‘JAK inhibition in STING-associated interferonopathy’ by Crow et al Victoria Tüngler, Nadja König, Claudia Günther et al. · Annals of the Rheumatic Diseases Open access	4 Nov 2016	34
41	Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies Andreas Schwarting, Tamara Möckel, Freya Lütgendorf et al. · Annals of the Rheumatic Diseases	11 Jun 2019	33
42	Usefulness scale for patient information material (USE) - development and psychometric properties Lars P. Hölzel, Zivile Ries, Jörg Dirmaier et al. · BMC Medical Informatics and Decision Making Open access	18 Apr 2015	33
43	Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial Juliana Rachel Hoeper, Jan Zeidler, Sara Eileen Meyer et al. · RMD Open Open access	Apr 2021	31
44	A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus Andrea. Schwartz Doria, Damon Bass, Andreas Schwarting et al. · Lupus Open access	28 May 2018	30
45	Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3 Manfred Relle, Bernd Föhr, Federica Fasola et al. · Molecular and Cellular Probes	24 Aug 2016	30
46	Neufassung der Strukturqualität der akut-stationären Rheumatologie H.‐J. Lakomek, Joseph M. Braun, Erika Gromnica‐Ihle et al. · Zeitschrift für Rheumatologie	19 Aug 2011	29
47	Adaptation des Composite International Diagnostic Interview (CIDI) zur Erfassung komorbider psychischer Störungen in der Onkologie: das CIDI-O Bianca Hund, Katrin Reuter, Frank Jacobi et al. · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie	16 Dec 2013	26
48	Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients Yue Qiu, Yuan Hu, Zuo-Yang Zhang et al. · Journal of Cancer Research and Clinical Oncology Open access	9 Jul 2014	26
49	Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data Markus Rehberg, Clemens Giegerich, Amy H. Praestgaard et al. · Rheumatology and Therapy Open access	14 Sep 2021	25
50	Früh- und Screeningsprechstunden: Ein notwendiger Weg zur besseren Frühversorgung in der internistischen Rheumatologie? Karolina Benesova et al. · Zeitschrift für Rheumatologie	29 Aug 2019	24

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.